Drug
Combination OF Lonsurf And Irinotecan
Combination OF Lonsurf And Irinotecan: highest development phase Phase 2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Combination of Lonsurf® and Irinotecan NCT04059562 | Phase 2 | Cholangiocarcinoma |
Latest
No recent events.
Follow Combination OF Lonsurf And Irinotecan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.